ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Brain Stim MeRT Therapy Introduces Groundbreaking Treatment for PTSD

Calabasas, CA (Newsworthy.ai) Wednesday Jan 24, 2024 @ 7:00 AM Eastern —

Brain Stim is leading a revolution in the treatment of Post-Traumatic Stress Disorder (PTSD) with its non-invasive and drug-free approach. Through the utilization of Magnetic e-resonance Therapy (MeRT) or Transcranial Magnetic Stimulation (TMS), this breakthrough treatment stimulates specific areas of the brain that are not functioning optimally, resulting in significant reductions in PTSD symptoms.

PTSD, a mental health disorder that develops after experiencing a traumatic event, affects millions of individuals worldwide. Symptoms often include heightened feelings of danger and fear, leading to stress and anxiety, even in safe environments. With MeRT Therapy, patients can find hope in managing and alleviating these debilitating effects.

Brain Stim ensures that each patient receives a customized treatment plan tailored to their unique needs by incorporating advanced diagnostic tools and imaging. The therapy also addresses other related conditions, such as depression and anxiety, which often coexist with PTSD.

Individuals who suspect they may have PTSD are encouraged to contact the New Patient Coordinator at MeRT Therapy or fill out the form on the website to schedule a consultation and learn more about the treatment options available.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here Brain Stim MeRT Therapy Introduces Groundbreaking Treatment for PTSD.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.